ESR1 and breast cancer: We also discuss potential limitations of this approach, specifically concerning robust automated distinction between pre-existing breast epithelium and well differentiated ER/PR positive breast cancer, and outline perspectives how to overcome such challenges in advanced image analysis by approaches tailored to tumor morphology and immunophenotype.